Healthcare
Live Price
Offline$0.1295
+24.64% today
Window Change
+355.99%
Window
Jun 23, 2025 โ May 15, 2026
Coverage: 225 bars ยท Jun 23, 2025 โ May 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Bristol-Myers Squibb Company Ce (CELG-RI) is a Healthcare stock with a market cap of $264.45M. The stock last traded around $0.13 and up 356.0% across the available one-year price window (Jun 23, 2025 โ May 15, 2026). Baseline metrics include revenue growth of -0.2%, EPS growth of +178.7%, a dividend yield of 0.0%. What stands out right now is revenue -0.2%, EPS +178.7%, free cash flow -7.9% with operating margin 34.0% and ROIC 13.6%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CELG-RI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CELG-RI
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
CELG-RI Max Drawdown
-64.27%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for CELG-RI and SPY.
Next Step
Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.